Best Practice & Research Clinical Rheumatology
Volume 20, Issue 4 , Pages 721-740 , August 2006

Osteoarthritis: rational approach to treating the individual

  • Peter Jüni, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Division of Clinical Epidemiology and Biostatistics, Department of Social and Preventive Medicine, University of Berne, Finkenhubelweg 11, 3012 Berne, Switzerland. Tel.: +41 31 631 33 78; Fax: +41 31 631 35 20.

References 

  1. In:  Murray CJL,  Lopez AD editor. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2002. Geneva: World Health Organization; 1996;
  2. Elders MJ. The increasing impact of arthritis on public health. The Journal of Rheumatology. 2000;60(supplement):6–8
  3. Dieppe PA, Reichenbach S, Williams S, et al. Assessing bone loss on radiographs of the knee in osteoarthritis: a cross-sectional study. Arthritis and Rheumatism. 2005;52:3536–3541
  4. Creamer P, Hochberg MC. Why does osteoarthritis of the knee hurt – sometimes?. British Journal of Rheumatology. 1997;36:726–728
  5. Felson DT. Epidemiology of hip and knee osteoartritis. Epidemiologic Reviews. 1988;10:1–28
  6. McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Knee pain and disability in the community. British Journal of Rheumatology. 1992;31:189–192
  7. Jüni P, Dieppe P, Donovan J, et al. Population requirement for primary knee replacement surgery: a cross-sectional study. Rheumatology (Oxford). 2003;42:516–521
  8. McAlindon TE, Snow S, Cooper C, Dieppe PA. Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Annals of the Rheumatic Diseases. 1992;51:844–849
  9. Hill CL, Gale DR, Chaisson CE, et al. Periarticular lesions detected on magnetic resonance imaging: prevalence in knees with and without symptoms. Arthritis and Rheumatism. 2003;48:2836–2844
  10. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA. 2003;290:2428–2429
  11. Altman RD. The classification of osteoarthritis. The Journal of Rheumatology. 1995;43(supplement):42–43
  12. Lawrence JS, Bremner JM, Bier F. Osteo-arthrosis. Prevalence in the population and relationship between symptoms and x-ray changes. Annals of the Rheumatic Diseases. 1966;25:1–24
  13. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteorthritis of the hip or knee. The Journal of Rheumatology. 1988;15:1833–1840
  14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  15. McAlindon TE, LaValley MP, Felson DT. Efficacy of glucosamine and chondroitin for treatment of osteoarthritis. JAMA. 2000;284:1241
  16. Chan AW, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457–2465
  17. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn.. Hillsdale: Lawrence Erlbaum; 1988;
  18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  19. Dieppe P, Cushnaghan J, Tucker M, et al. The Bristol 'OA500 study': progression and impact of the disease after 8 years. Osteoarthritis Cartilage. 2000;8:63–68
  20. Warsi A, LaValley MP, Wang PS, et al. Arthritis self-management education programs: a meta-analyisis of the effect on pain and disability. Arthritis and Rheumatism. 2003;48:2207–2213
  21. Amadio PJ, Cummings DM. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Current Therapeutic Research, Clinical and Experimental. 1983;34:59–66
  22. Zoppi M, Peretti G, Boccard E. Placebo-controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or hip. European Journal of Pain. 1995;16:42–48
  23. Case JP, Baliunas AJ, Block JA. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Archives of Internal Medicine. 2003;163:169–178
  24. Zwahlen M, Jüni P, Egger M. What now about acetaminophen?. Archives of Internal Medicine. 2003;163:169–178
  25. Pincus T, Koch G, Lei H, et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the Rheumatic Diseases. 2004;63:931–939
  26. Miceli-Richard C, Le Bars M, Schmidely N, Dougados M. Paracetamol in osteoarthritis of the knee. Annals of the Rheumatic Diseases. 2004;63:923–930
  27. Neame R, Zhang W, Doherty M. A historic issue of the Annals: three papers examine paracetamol in osteoarthritis. Annals of the Rheumatic Diseases. 2004;63:897–900
  28. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Annals of the Rheumatic Diseases. 2004;63:901–907
  29. Moore RA, Tramèr MR, Carroll D, et al. Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316:333–338
  30. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329:324–326
  31. McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. The Journal of Rheumatology. 1992;19:604–607
  32. Chard J, Dieppe P. Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe – but there's no good evidence that it works. BMJ. 2001;322:1439–1440
  33. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251–256
  34. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Archives of Internal Medicine. 2002;162:2113–2123
  35. Malaise M, Marcolongo R, Uebelhart D, Vignon E. Efficacy and tolerability of 800 mg oral chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: a randomised, double-blind, multicentre study vs placebo. Litera Rheumatol. 1999;24:32–42
  36. Mazieres B, Combe B, Van AP, et al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. The Journal of Rheumatology. 2001;28:173–181
  37. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454–465
  38. Richy F, Bruyere O, Ethgen O, et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Annals of the Rheumatic Diseases. 2004;63:759–766
  39. Scott D, Smith C, Lohmander S, Chard JA. Osteoarthritis. In:  Godlee F editors. Clinical Evidence. 9th edn.. London: BMJ; 2003;
  40. Gøtzsche PC. Non-steroidal anti-inflammatory drugs. In:  Godlee F editors. Clinical Evidence. 9th edn.. London: BMJ; 2003;
  41. Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs vs basic analgesia in treating the pain of degenerative arthritis. BMJ. 1998;317:526–530
  42. Pincus T, Koch GG, Sokka T, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol vs acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis and Rheumatism. 2001;44:1587–1598
  43. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients – a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis and Rheumatism. 2000;43:378–385
  44. Courtney P, Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthritis. Annals of the Rheumatic Diseases. 2002;61:767–773
  45. March L, Irwig L, Schwarz J, et al. n Of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ. 1994;309:1041–1045
  46. Wegman AC, van der Windt DA, de Haan M, et al. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Annals of the Rheumatic Diseases. 2003;62:1156–1161
  47. Jüni P, Rutjes AW, Dieppe PA. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?. BMJ. 2002;324:1287–1288
  48. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954–959
  49. Jüni P, Dieppe P, Egger M. Risk of myocardial infarction associated with selective COX-2 inhibitors: questions remain. Archives of Internal Medicine. 2002;162:2639–2642
  50. Jüni P, Nartey L, Reichenbach S, et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364:2021–2029
  51. Spiegel BMR, Targownik L, Dulai GS, Gralnek IM. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Annals of Internal Medicine. 2003;138:795–806
  52. Jüni P, Dieppe P. Older people should NOT be prescribed `coxibs' in place of conventional NSAIDs. Age Ageing. 2004;33:100–104
  53. van Baar ME, Assendelft WJ, Dekker J, et al. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis and Rheumatism. 1999;42:1361–1369
  54. O'Reilly SC, Muir KR, Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Annals of the Rheumatic Diseases. 1999;58:15–19
  55. Peloquin L, Bravo G, Gauthier P, et al. Effects of a cross-training exercise program in persons with osteoarthritis of the knee. A randomized controlled trial. Journal of Clinical Rheumatology. 1999;5:126–136
  56. Petrella RJ, Bartha C. Home based exercise therapy for older patients with knee osteoarthritis: a randomized clinical trial. The Journal of Rheumatology. 2000;27:2215–2221
  57. van Baar ME, Dekker J, Oostendorp RAB, et al. Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months' follow up. Annals of the Rheumatic Diseases. 2001;60:1123–1130
  58. Fransen M, Crosbie J, Edmonds J. Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial. The Journal of Rheumatology. 2001;28:156–164
  59. Thomas KS, Muir KR, Doherty M, et al. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ. 2002;325:752
  60. Hinman RS, Crossley KM, McConnell J, Bennell KL. Efficacy of knee tape in the management of osteoarthritis of the knee: blinded randomised controlled trial. BMJ. 2003;327:135
  61. Toda Y, Segal N. Usefulness of an insole with subtalar strapping for analgesia in patients with medial compartment osteoarthritis of the knee. Arthritis and Rheumatism. 2002;47:468–473
  62. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. The Journal of Rheumatology. 1993;20(supplement 39):3–9
  63. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 2004;328:869
  64. Brandt KD, Smith GN, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?. Arthritis and Rheumatism. 2000;43:1192–1203
  65. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis and Cartilage. 1993;1:97–103
  66. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290:3115–3121
  67. McLaren AC, Blokker CP, Fowler PJ, et al. Arthroscopic debridement of the knee for osteoarthrosis. Canadian Journal of Surgery. 1991;34:595–598
  68. Gross DE, Brenner SL, Esformes I, Gross ML. Arthroscopic treatment of degenerative joint disease of the knee. Orthopedics. 1991;14:1317–1321
  69. Chang RW, Falconer J, Stulberg S, et al. A randomized, controlled trial of arthroscopic surgery vs closed-needle joint lavage for patients with osteoarthritis of the knee. Arthritis and Rheumatism. 1993;36:289–295
  70. McEldowney AJ, Weiker GG. Open-knee Magnuson debridement as conservative treatment for degenerative osteoarthritis of the knee. The Journal of Arthroplasty. 1995;10:805–809
  71. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. The New England Journal of Medicine. 2002;347:81–88
  72. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. The New England Journal of Medicine. 2001;344:1594–1602
  73. Fortin PR, Penrod JR, Clarke AE, et al. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis and Rheumatism. 2002;46:3327–3330
  74. Ashworth MA, Brule C, Day A, et al. The Development of an Orthopedic Waiting List Algorithm for Elective Total Hip and Total Knee Replacement Surgery. Ottawa, Ontario, Canada: Canadian Health Services Research Foundation; 2002;
  75. Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following uni-compartmental or bi-compartmental knee arthroplasty: a meta analysis. The Journal of Arthroplasty. 1995;10:141–150
  76. Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following tricompartmental total knee replacement: a meta-analysis. JAMA. 1994;271:1349–1357
  77. Hajat S, Fitzpatrick R, Morris R, et al. Does waiting for total hip replacement matter? Prospective cohort study. Journal of Health Services Research & Policy. 2002;7:19–25
  78. Kennedy LG, Newman JH, Ackroyd C, Dieppe PA. When should we do knee replacements?. Knee. 2003;10:161–166
  79. Murray DW, Britton AR, Bulstrode CJK. Loss to follow-up matters. The Journal of Bone and Joint Surgery. 1997;79B:254–257
  80. Mahomed NN, Barrett JA, Katz JN, et al. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. The Journal of Bone and Joint Surgery. 2003;85A:27–32
  81. Freund DA. Assessing and Improving Outcomes: Total Knee Replacement: Patient Outcomes Research Team (PORT): Final Report. Maryland: Agency for Health Care Policy and Research; 1997;
  82. Faulkner A, Kennedy LG, Baxter K, et al. Effectiveness of hip prostheses in primary total hip replacement. Health Technology Assessment. 1998;2:1–133
  83. Chang RW, Pellissier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA. 1996;275:858–865
  84. Robertsson O, Lewold S, Knutson K, Lidgren L. The Swedish Knee Arthroplasty Project. Acta Orthopaedica Scandinavica. 2003;71:7–18
  85. Young NL, Cheah D, Waddell J, Wright JG. Patient characteristics that affect the outcome of total hip arthroplasty: a review. Canadian Journal of Surgery. 1998;41:188–195
  86. NIH consensus conference: total hip replacement . NIH consensus development panel on total hip replacement. JAMA. 1995;273:1950–1956
  87. Naylor CD, Williams JI. Primary hip and knee replacement surgery: Ontario criteria for case selection and surgical priority. Quality in Health Care. 1995;5:20–30
  88. Hardorn DC, Homes AC. The New Zealand priority criteria project. BMJ. 1997;314:131–134
  89. Nilsdotter AK, Aurell Y, Siosteen AK, et al. Radiographic stage of osteoarthritis or sex of the patient does not predict one year outcome after total hip arthroplasty. Annals of the Rheumatic Diseases. 2000;60:228–232
  90. Chard JA, Tallon D, Dieppe PA. Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Annals of the Rheumatic Diseases. 2000;59:414–418
  91. Emkey R, Rosenthal N, Wu SC, et al. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. The Journal of Rheumatology. 2004;31:150–156
  92. Messier SP, Loeser RF, Miller GD, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis and Rheumatism. 2004;50:1501–1510
  93. Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. The Journal of Rheumatology. 1990;17:364–372
  94. Summers MN, Haley WE, Reveille GS, Alarcon JD. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis and Rheumatism. 1988;31:204–209
  95. Zochling J, March L, Lapsley H, et al. Use of complementary medicines for osteoarthritis – a prospective study. Annals of the Rheumatic Diseases. 2004;63:549–554
  96. Weiner DK, Ernst E. Complementary and alternative approaches to the treatment of persistent musculoskeletal pain. The Clinical Journal of Pain. 2004;20:244–255
  97. Ezzo J, Hadhazy V, Birch S, et al. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis and Rheumatism. 2001;44:819–825

PII: S1521-6942(06)00050-7

doi: 10.1016/j.berh.2006.05.002

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 4 , Pages 721-740 , August 2006

Article Tools

* Image Usage & Resolution